Glucose Sensing in L Cells: A Primary Cell Study  by Reimann, Frank et al.
Cell Metabolism
Short ArticleGlucose Sensing in L Cells: A Primary Cell Study
Frank Reimann,1,2 Abdella M. Habib,1,2 Gwen Tolhurst,1 Helen E. Parker,1 Gareth J. Rogers,1 and Fiona M. Gribble1,*
1Cambridge Institute for Medical Research and Department of Clinical Biochemistry, Addenbrooke’s Hospital,
Hills Road, Cambridge CB2 0XY, UK
2These authors contributed equally to this work
*Correspondence: fmg23@cam.ac.uk
DOI 10.1016/j.cmet.2008.11.002SUMMARY
Glucagon-like peptide-1 (GLP-1) is an enteric hor-
mone that stimulates insulin secretion and improves
glycaemia in type 2 diabetes. Although GLP-1-based
treatments are clinically available, alternative strate-
gies to increase endogenous GLP-1 release from
L cells are hampered by our limited physiological
understanding of this cell type. By generating trans-
genic mice with L cell-specific expression of a fluo-
rescent protein, we studied the characteristics of
primary L cells by electrophysiology, fluorescence
calcium imaging, and expression analysis and show
that single L cells are electrically excitable and glu-
cose responsive. Sensitivity to tolbutamide and low-
millimolar concentrations of glucose and a-methyl-
glucopyranoside, assessed in single L cells and by
hormone secretion from primary cultures, suggested
that GLP-1 release is regulated by the activity of so-
dium glucose cotransporter 1 and ATP-sensitive K+
channels, consistent with their high expression levels
in purified L cells by quantitative RT-PCR. These and
other pathways identified using this approach will
provide exciting opportunities for future physiologi-
cal and therapeutic exploration.
INTRODUCTION
Enteroendocrine L cells secrete a number of physiologically im-
portant peptides, including glucagon-like peptide-1 (GLP-1),
glucagon-like peptide-2 (GLP-2), peptide YY (PYY) and oxynto-
modulin. Each of these hormones is under evaluation for poten-
tial therapeutic applications in humans. GLP-1 mimetics and
inhibitors of GLP-1 degradation are already licensed for the
treatment of type 2 diabetes, exploiting the important role of
GLP-1 in the stimulation and maintenance of insulin release
from pancreatic b cells and in the control of appetite (Drucker
and Nauck, 2006; Holst, 2007). GLP-2, by contrast, enhances re-
generation and repair of the intestinal epithelium (Estall and
Drucker, 2006), whereas PYY and oxyntomodulin reduce food
intake in rodents and humans (Wynne and Bloom, 2006). Target-
ing secretion from the L cell, therefore, provides exciting new
therapeutic opportunities, and a more detailed characterization
of the molecular and cellular physiology of this cell type is ur-
gently needed to fuel the future progress of this research field.
L cells form a component of the diffuse enteroendocrine sys-
tem, which includes a variety of endocrine cell types scattered
Open access under CC BY license.532 Cell Metabolism 8, 532–539, December 3, 2008 ª2008 Elsevieralong the length of the intestinal epithelium. To date, the dis-
persed nature of enteroendocrine cells has largely precluded
their interrogation by single-cell physiological techniques. Hista-
mine-producing enterochromaffin-like cells, which can be par-
tially purified and maintained in short-term culture, are regulated
by voltage-dependent calcium entry but are not believed to be
electrically active, as they lack voltage-gated sodium currents
(Bufler et al., 1998). For most other enteroendocrine cell types,
single-cell characterization has been restricted to the study of
model cell lines. GLUTag, STC-1, and NCI-H716 cells secrete
GLP-1 (Drucker et al., 1994; Abello et al., 1994; Reimer et al.,
2001) but exhibit different nutrient sensitivities and are incom-
pletely validated as accurate models of the native L cell. While
GLP-1 release has also been studied in primary cultures of fetal
rat intestinal cells (Brubaker and Vranic, 1987), establishing
cultures from adult intestinal tissue has presented more of a
challenge.
GLP-1 release is triggered by ingestion of carbohydrates, fats,
and protein and is believed to reflect, at least in part, the direct
sensing of luminal nutrients by the apical processes of the L cells.
In GLUTag cells, we previously identified two distinct pathways
that couple GLP-1 secretion to glucose exposure, one involving
the classical glucose-sensing machinery employed by the pan-
creatic b cell, mediated through glucose metabolism and closure
of ATP-sensitive potassium (KATP) channels, and the other ex-
ploiting the electrogenic nature of Na+-coupled glucose uptake
by sodium glucose cotransporters (SGLTs) (Reimann and Grib-
ble, 2002; Gribble et al., 2003). However, subunits of the taste re-
ceptor pathway (Tas1 receptors anda-gustducin) have also been
detected in intestinal cells, including some cells that coexpress
GLP-1 (Sutherland et al., 2007), and recent evidence suggests
that they may contribute to the stimulation of GLP-1 release
and the upregulation of intestinal SGLT1 expression following
sugar ingestion (Jang et al., 2007; Margolskee et al., 2007).
To enable a molecular and single-cell characterization of
GLP-1 secretory mechanisms, we made a transgenic mouse
model in which cells expressing proglucagon were labeled by
the yellow fluorescent protein, Venus (Nagai et al., 2002). This
was used to interrogate components of the stimulus-secretion
coupling pathways underlying GLP-1 release, using electrophys-
iological recordings and fluorescence-based calcium measure-
ments from identified adult murine L cells in primary culture
and supported by expression analysis and measurements of
hormone secretion from primary intestinal cultures.
RESULTS
Pronuclear injection of BAC constructs containing the Venus
sequence in the place of the coding region of proglucagonInc.
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Figure S1 available online) resulted in the generation of five
founder mice with 1 to 12 copies of the transgene, as assessed
by quantitative PCR. Sporadic yellow fluorescent cells were ob-
served in freshly harvested tissue from the gastrointestinal tract,
pancreatic islets, and brainstem of the transgenic mice, coincid-
ing with the known locations of GLP-1 and glucagon expression
(Larsson et al., 1975; Larsen et al., 1997). As we observed no
differences between the strains in the global pattern of Venus
expression in the gut and pancreas, the five strains were used
interchangeably for the remainder of the study.
In the gut, Venus-positive cells increased in density along the
intestinal axis from the duodenum to the colon in agreement with
previous descriptions of GLP-1-positive cells identified by immu-
nohistochemistry (Larsson et al., 1975). The cells were located in
both crypts and villi and were frequently observed to have thin
processes extending to the gut lumen. In all strains, Venus fluo-
rescence in the intestine coincided with immunofluorescence
staining for proglucagon (Figure 1A). Proglucagon gene expres-
sion was 11,000-fold higher, and GLP-1 protein content was
>7000-fold higher in Venus-positive cells (Lpos) purified by
FACS (Figure 1B) than in nonfluorescent cells collected in parallel
(Lneg), thus confirming the cell specificity of expression of the
fluorescent transgene (Figures 1C and 1D). Consistent with pre-
vious reports, Lpos cells in the gut also produced PYY, detectable
at the mRNA and protein levels as well as by immunofluores-
cence staining (Figures 1C, 1D, and S1B). GIP mRNA (data not
shown) and protein (Figure 1D) was found in L cells from the
small intestine only, although their GIP protein content was
6-fold lower than that of K cells purified by a similar method
(F.R., unpublished data). These results are compatible with pre-
vious reports that GIP is detectable by immunostaining in a sub-
set of small intestinal L cells (Mortensen et al., 2003).
In pancreatic islets, Venus fluorescence colocalized with pro-
glucagon immunostaining, confirming the identity of the labeled
cells as glucagon-producing a cells (Figure S2A). Islet cells from
the transgenic mice could be separated by flow cytometry into
relatively pure populations of a and b cells and a mixed popula-
tion of d and pancreatic polypeptide (PP) cells, as assessed by
their hormone expression profiles measured by quantitative
RT-PCR (Figures S2B and S2C).
Primary Intestinal Cultures
As FACS-sorted single L cells did not survive in culture, we gen-
erated mixed primary cultures from adult mouse small intestine
or colon, which could be maintained for up to 2 weeks. Venus-
positive cells in the cultures were immunopositive for glucagon
and PYY (Figure S1D). Cell proliferation, assessed by EdU incor-
poration, was evident in the nonfluorescent cell population, but
not in the 154 Lpos cells examined (Figure S1E). In 8-day-old co-
lonic cultures, forskolin plus isobutyl-1-methylxanthine (IBMX,
10 mM of each) enhanced GLP-1 release 9-fold and PYY release
6-fold (n = 3 of each, data not shown), indicating that the L cells in
culture were functionally viable.
Electrical Activity in Colonic L Cells
L cells were readily distinguishable in culture by their Venus fluo-
rescence (Figure 2A). In perforated patch recordings, they were
electrically excitable and exhibited an increase in action potentialCellfrequency following addition of glucose or the sulphonylurea
tolbutamide (Figures 2B and 2C). Conventional whole-cell re-
cordings with a low pipette ATP concentration (0.3 mM) revealed
a tolbutamide-sensitive current that developed over the course
of 2–5 min, confirming the presence of functional KATP channels
in primary L cells (Figure 2D).
Calcium Responses in Colonic L Cells
Cultured L cells, identified by their Venus fluorescence, exhibited
intracellular calcium ([Ca2+]i) elevations (Figures 2E, 2F, and 2G)
Figure 1. Cell-Specific Venus Expression in Transgenic Mice
(A) Colocalization of Venus fluorescence (green) with glucagon immunofluo-
rescence (red) in the small intestine. Scale bar, 20 mm.
(B) L cells were collected by FACS sorting with gates on pulse width, side and
forward scatter to select single cells and yellow (580 nm) and green (530 nm)
fluorescence to select Venus-positive (R1) or Venus-negative (R2) cells (exci-
tation 488 nm). The figure shows a representative sort from the small intestine.
(C) Relative expression of proglucagon and Pyy mRNAs in GLUTag cells and
Lpos and Lneg cells from different regions of the intestine (middle third of small
intestine [mid S1], lower third of small intestine [lower S1], and colon). Data
are presented as geometric mean and upper SE (n R 3 each). **p < 0.01,
***p < 0.001 by Student’s t test.
(D) GIP, GLP-1, and PYY peptide contents in Lpos and Lneg cells from the
small intestine (upper half, Up SI) or colon, as indicated, collected by FACS
sorting and measured by ELISA. Data represent mean and SE ofR 3 samples
with statistical comparisons between corresponding Lpos and Lneg cells. **p <
0.01, ***p < 0.001. ND, not detected.Metabolism 8, 532–539, December 3, 2008 ª2008 Elsevier Inc. 533
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Glucose Sensing by L CellsFigure 2. Electrical Activity and [Ca2+]i in
Cultured Colonic L Cells
(A) Colonic epithelial cells fixed after 10 days in
primary culture. DIC, DAPI (blue), Venus (green).
(B) Glucose-triggered electrical activity in L cells.
(Left) Representative whole-cell perforated patch
current clamp recording of a Venus-positive cell
stimulated with glucose (10 mM) applied as indi-
cated. (Right) Average action potential frequency
before (C1), during (Gluc), and after (C2) applica-
tion of glucose measured in eight cells. Error bars
represent 1 SE and significance, between AP-fre-
quency in the presence and absence of glucose
was tested by Student’s paired t test. **p < 0.01.
(C) Average action potential frequency before (C1),
during (tolb), and after (C2) application of tolbuta-
mide (500 mM) measured in nine cells, as in (B).
Error bars represent 1 SE, and significance be-
tween AP-frequency in the presence and absence
of tolbutamide was tested by Student’s paired
t test. **p < 0.01.
(D) Functional KATP wash-out currents in cultured
L cells. (Left) Slope conductances between 70
and 50 mV were recorded from a cell in conven-
tional whole-cell voltage clamp. The arrow indicates
the time when the cell attached mode was con-
verted into conventional whole cell with 300 mM
ATP in the pipette. Tolbutamide (tolb, 500 mM) was
appliedatsteadystate,as indicated. (Right)Average
conductances measured as exemplified on the left
in five cells at times (a) cell attached, (b) wash-out
steady state,and (c)afterapplicationof tolbutamide.
Error bars represent 1 SE, and significance was
tested by Student’s paired t test. ***p < 0.001.
(E)Lpos and Lneg cells incolonic cultureswere loaded
with fura2-AM and identified by their presence/
absence of Venus fluorescence (475 nm excitation,
left). The image of fura2-loaded cells excited at
340 nm (right) was used to outline Lpos (green) and
Lneg (red) cells.
(F) The 340/380 nm fluorescence ratios (reflecting
[Ca2+]i) of the two cells outlined in (E) are shown fol-
lowing addition of 10 mM glucose to the perfusate.
Green trace, Lpos cell; red trace, Lneg cell.
(G) Mean calcium changes in Lpos (green bars) and Lneg (red bars) cells, identified and monitored as in (E) and (F), following the addition of glucose (Gluc, 10 mM),
aMG (10 mM), tolbutamide (tolb, 100 mM), KCl (30 mM), sucralose (sucl, 1 or 20 mM), bombesin (Bb, 100 nM), and forskolin/IBMX (F/I, 10 mM of each), as indicated.
340/380 ratios in the presence of the test agent were normalized to the mean of the background ratios of each cell measured before addition and after washout of the
test compound. Data represent the mean and SE of the number of cells indicated above each bar.Dp < 0.05,DDp < 0.01, andDDDp < 0.001 compared with baseline.
*p < 0.05, **p < 0.01, and ***p < 0.001 for comparison between corresponding Lpos and Lneg cells by Student’s t test.in response to glucose (10 mM), a-methylglucopyranoside
(aMG, 10 mM), tolbutamide (100 mM), KCl (30 mM), forskolin/
IBMX (10 mM of each), or bombesin (100 nM), but not to the arti-
ficial sweetener sucralose (1 mM or 20 mM). Lneg cells were sig-
nificantly less responsive than L cells to glucose, tolbutamide,
KCl, and bombesin, and a proportion of Lneg cells, but not Lpos
cells, responded to sucralose. The significantly greater effects
of glucose and tolbutamide on Lpos cells than on Lneg cells
suggest that glucose responsiveness originates in the L cells
themselves.
GLP-1 Secretion from Primary Cultures
Although glucose-triggered GLP-1 release has been well docu-
mented in vivo, as well as in whole intestinal preparations and
GLUTag cells (Herrmann et al., 1995; Plaisancie´ et al., 1995;534 Cell Metabolism 8, 532–539, December 3, 2008 ª2008 ElsevierReimann and Gribble, 2002), a lack of glucose responsiveness
of fetal rat intestinal cultures and primary cultured canine L cells
(Brubaker and Vranic, 1987; Damholt et al., 1998) has led to
doubts about whether L cells are themselves glucose sensitive.
In primary cultures of small intestine and colon, however, GLP-1
secretion was glucose dependent, with EC50s of 4 mM and
0.7 mM, respectively (not significantly different, Figures 3A and
3B). To examine the relative roles of SGLT1 and KATP channels
in L cells, we measured GLP-1 responses to the SGLT1 sub-
strate, aMG, or to tolbutamide (Figures 3C and 3D). GLP-1 re-
lease was triggered by aMG with a measured EC50 in the small
intestine of 0.2 mM (data not shown), not significantly different
than that for glucose and similar to the Km for SGLT1 of
0.3 mM (Dı´ez-Sampedro et al., 2000). Secretion was also stimu-
lated by tolbutamide, confirming a functional role for KATPInc.
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Glucose Sensing by L CellsFigure 3. GLP-1 Secretion from Primary Intestinal
Cultures
(A and B) Mixed primary cultures from the upper half of the
small intestine (A) or the colon (B) were incubated in bath
solution containing the glucose concentrations indicated.
The percentage of GLP-1 secretion in each well is ex-
pressed relative to the basal secretion measured in paral-
lel on the same day. Dose-response curves were fitted
through the entire data set using a logistic equation, giving
EC50s of 4 mM and 0.7 mM for the small intestine and co-
lon, respectively (not significantly different). Error bars rep-
resent 1 SE, and significance is shown relative to baseline
using a single-factor t test. *p < 0.05, **p < 0.01, ***p <
0.001.
(C) GLP-1 secretion from primary colonic cultures trig-
gered by forskolin/IBMX (F/I, 10 mM of each), bombesin
(Bb, 100 nM), or glucose (Gluc, 10 mM), as indicated, mea-
sured and expressed as in (A). Error bars represent 1 SE,
and significance is shown relative to baseline using a sin-
gle-factor t test: ***p < 0.001. The additional effect of glu-
cose was analyzed by regression analysis to compensate
for variation in the effectiveness of forskolin/IBMX or
bombesin between different experiments: DDDp < 0.001.
(D and E) GLP-1 secretion from the upper small intestine
(D) or colon (E), measured as in (A), following addition of glucose (Gluc, 10 mM), aMG (10 mM), tolbutamide (tolb, 500 mM), sucralose (sucl, 1 or 20 mM), or ace-
sulfame K (AceK, 2 mM). The control bar (Con) and dashed line indicate the basal rate of secretion. Data represent the mean and SE of the number of wells in-
dicated, and significance is shown relative to baseline, tested by a single-factor t test. *p < 0.05, ** p < 0.01. n.s., not significant.channels. By contrast, GLP-1 secretion was not triggered by
1 mM sucralose or 2 mM acesulfame K, agents that specifically
target sweet taste receptors (Figures 3C and 3D). At a higher
concentration of 20 mM, sucralose increased GLP-1 release
from colonic cultures, but not small intestinal cultures, an effect
that was additive with glucose and therefore likely to act via an
independent pathway (Figure S3). Overnight pretreatment of co-
lonic cultures with 20 mM sucralose did not affect either basal
GLP-1 release or the subsequent response to 10 mM glucose
(Figure S3).
Expression of Candidate Glucose-Sensing Machinery
in Purified L and Islet Cells
To confirm the identity and expression of candidate glucose-
sensing components in L cells, FACS-sorted Lpos and Lneg cells
were analyzed by quantitative RT-PCR, using probe sets against
KATP channel subunits (Kir6.2, Sur1), glucokinase (Gck), facilita-
tive glucose transporters (Glut1, 2, 3, and 5), sodium-coupled
glucose transporter 1 (Sglt1), taste receptor subunits (Tas1R1,
R2, and R3), and a-gustducin. Comparisons were made with ex-
pression levels in GLUTag and STC-1 cells, different islet cell
populations, and tongue epithelium (Figure 4 and Table S1).
KATP Channels and Glucokinase
L cells expressed Kir6.2, SUR1, and glucokinase (Gck) at levels
that were enhanced several hundred-fold compared with Venus-
negative controls and with no apparent differences along the in-
testinal axis. Expression levels were comparable with those found
in pancreatic a, b, and d/PP cells. Kir6.2 expression was lower
even in STC-1 cells than in GLUTag cells (p = 0.002), consistent
with a previous report that hormone secretion from an STC-1 sub-
clone was KATP channel independent (Wang et al., 2003).
Facilitative Glucose Transporters
Glut1 expression was similar in Lpos and Lneg cells and increased
from the midsmall intestine to colon, whereas Glut2 expressionCellwas highest proximally and decreased along the gut axis in
both Lpos and Lneg cells. Glut5 was abundant in small intestinal
Lneg cells and all Lpos cell populations examined but was
70-fold lower in colonic Lneg than colonic Lpos cells. In pancreatic
islets, Glut2 expression was 1200-fold higher and Glut5 5-fold
higher in b than a cells, whereas both Glut1 and Glut3 were
expressed at similar low levels in both cell types.
Sodium-Coupled Glucose Transporters
Sglt1 was highly expressed in both Lpos and Lneg cells from the
small intestine, consistent with its known role in epithelial glu-
cose absorption, whereas, in the colon, we observed a 9-fold
lower level of expression in Lneg than Lpos cells (p = 0.002). Immu-
nofluorescence staining localized SGLT1 to the apical mem-
brane of ileal enterocytes and L cells (Figure S1C), and, in colonic
cultures, the predominance of SGLT1 in Lpos compared with Lneg
cells was also evident by immunostaining (Figure S1F). Sglt1
expression was barely detectable in the islets.
Sweet Taste Receptors
The taste receptor subunit Tas1R3 was expressed at low levels
in both the intestine and islets with no apparent difference be-
tween Lpos and Lneg cells (Table S1). Tas1R2 expression was
generally lower but could be detected in colonic and lower small
intestinal Lpos cells as well as pancreatic a cells. a-Gustducin
expression was detectable in pancreatic a cells and colonic
Lpos cells but was below the detection limit in most other cell
preparations tested. Although low, the expressions of the Tas1
receptors and a-gustducin are comparable with those measured
in the tongue epithelium, which is known to include a limited
proportion of taste-responsive cells.
Expression and Function of G Protein-Coupled Receptor
Pathways in L Cells
The ability of elevated cAMP or bombesin (Gq coupled) to in-
crease [Ca2+]i in L cells was shown above. These pathwaysMetabolism 8, 532–539, December 3, 2008 ª2008 Elsevier Inc. 535
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cultures (Figure 3E). GLP-1 release was triggered by forskolin/
IBMX or bombesin and was further enhanced by glucose, indi-
cating a potential synergistic interaction between depolarizing
stimuli and signaling pathways activated by G protein-coupled
receptors.
Lipids have been reported recently to stimulate L cells via
G protein-coupled receptors. The Gas-coupled receptor
GPR119 is an orphan G protein coupled receptor responsive
to the natural ligand oleoylethanolamide (Overton et al., 2006)
and is under evaluation as a therapeutic target in L cells (Chu
et al., 2008). The long chain fatty acid receptors GPR120 and
GPR40 and the bile acid receptor TGR5 have also been shown
to play functional roles in enteroendocrine cell lines (Hirasawa
et al., 2005; Katsuma et al., 2005). mRNAs for all of these GPCRs
were strongly expressed in FACS-sorted L cells (Figure 4).
DISCUSSION
By fluorescently labeling cells that express proglucagon in
a transgenic mouse, we show that primary L cells are electrically
excitable and directly nutrient responsive. The fluorescently
tagged L cells are suitable for patch clamping, single-cell dy-
namic calcium imaging, and cell sorting, providing a range of
new and powerful techniques to interrogate the function of this
enteroendocrine cell type. Our results support the idea that cer-
tain nutrients like glucose can directly stimulate L cells by trigger-
ing a cascade of membrane depolarization, action potential
firing, and voltage-dependent Ca2+ entry. Furthermore, as the
Figure 4. Expression Analysis
Expression of the genes indicated in GLUTag cells, Lpos
cells, and Lneg cells from three different regions of the
gut (middle third of small intestine [SI], lower third of small
intestine, and colon) and in pancreatic a, b, and d/PP cells
isolated as in Figure S2. Expression was normalized to that
of b-actin in the same sample. Data are presented as geo-
metric mean and upper SE (nR 3 each). Lpos and Lneg cells
were compared by Student’s t tests: *p < 0.05, **p < 0.01,
***p < 0.001. n.s., not significant.
electrical activity and glucose responsiveness
of primary mouse L cells mimicked our previous
findings on the GLUTag cell line (Reimann and
Gribble, 2002), our data support the validity of
using this cell line as a model for the native L
cell.
The low millimolar EC50 for glucose-triggered
GLP-1 release from primary intestinal cultures
(0.7–4 mM) is similar to that of GLUTag cells
(0.2 mM) (Gribble et al., 2003) and close to the
reported Km for SGLT1 of 0.3 mM (Dı´ez-Sampe-
dro et al., 2000). Indeed, the finding that the
nonmetabolizable glucose analog aMG also
triggered GLP-1 release with an EC50 of 0.2
mM suggests that SLGT1 is itself an L cell glu-
cose sensor. By contrast, GLUTag cells were
only responsive to aMG at 100 mM, consistent
with the 11-fold lower expression of Sglt1
mRNA in the cell line compared with small intestinal Lpos cells.
SGLT1 activity underlies a major component of apical membrane
glucose uptake in small intestinal enterocytes, utilizing the in-
wardly directed sodium gradient to drive glucose influx even at
low luminal glucose concentrations. Our results support previ-
ous reports that the ability of luminal sugars to stimulate GLP-1
release was both sodium dependent and matched the sugar
specificity of the intestinal glucose uptake pathway (Herrmann
et al., 1995; Ritzel et al., 1997). By contrast, the function of facil-
itative glucose transporters in L cells remains unclear, although
mice lacking GLUT2 had a lower intestinal GLP-1 content and
reduced plasma GLP-1 concentrations after an oral glucose tol-
erance test (Cani et al., 2007). If localized on the basolateral sur-
face as in enterocytes, they could provide an important glucose
efflux pathway as well as a potential route to respond to plasma
glucose changes. Although GLP-1 release is not stimulated by
intravenous glucose administration in fasting human subjects,
it was strongly influenced by the plasma glucose concentration
in a perfused porcine ileum preparation with a constant flow of
luminal glucose (Hansen et al., 2004).
L cells express glucokinase and have functional KATP chan-
nels, supporting a recent observation that Kir6.2 was detected
in human L cells by immunostaining (Nielsen et al., 2007). The
role of KATP channels in L cells is unclear, but it is possible that
they might be modulated by basolateral glucose and/or neuronal
inputs. As SGLT1-associated currents are relatively small, their
effectiveness would be determined by the magnitude of
other plasma membrane currents. Alterations of KATP channel
activity by metabolism or neurotransmitters might, therefore,536 Cell Metabolism 8, 532–539, December 3, 2008 ª2008 Elsevier Inc.
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glucose.
Although recent reports suggest that sweet taste receptor ac-
tivation stimulates GLP-1 secretion and increases intestinal
SGLT1 expression (Jang et al., 2007; Margolskee et al., 2007),
this is unlikely to explain our finding that GLP-1 release from
primary cultures was triggered by submillimolar glucose concen-
trations, as sweet taste receptors are typically activated by
30–1000 mM glucose and by low millimolar concentrations of su-
cralose and acesulfame K (Damak et al., 2003). We were unable
to demonstrate an effect of 1 mM sucralose on either GLP-1
release or [Ca2+]i in L cells, consistent with a recent report that
sweeteners do not stimulate GLP-1 release in vivo in rats
(F. Fujita et al., 2008, American Diabetes Association, abstract).
GLP-1 release from colonic cultures was, however, triggered by
a relatively high concentration of sucralose (20 mM), an effect
that was additive with glucose. Although we are unable to con-
clude whether the action of the higher concentration of the
sweetener is mediated by the sweet taste receptor pathway, co-
lonic Lpos cells did have detectable levels of Tas1R2, Tas1R3,
and a-gustducin expression, in agreement with previous reports
that a small subpopulation of GLP-1-positive cells also express
a-gustducin (Sutherland et al., 2007; Jang et al., 2007). In taste
buds, the coupling of sweet taste receptors to a-gustducin and
phospholipase Cb2 results in elevated [Ca2+]i and/or cAMP (Mar-
golskee, 2002). The lack of responsiveness of [Ca2+]i in cultured
L cells to sucralose does not appear to reflect a defect in poten-
tial downstream signaling pathways, as rapid [Ca2+]i changes in
L cells and GLP-1 secretion were triggered by forskolin/IBMX or
bombesin.
Glucose-triggered GLP-1 release was amplified by forskolin/
IBMX and additive with the response to bombesin. The potent ef-
fects of elevated cAMP and Gq-coupled receptor activation, to-
gether with the L cell-specific expression of receptors such as
Gpr40, Gpr120, Gpr119, and Tgr5 in the intestine, make these
pathways exciting targets for the future development of thera-
peutic L cell secretagogues. The availability of transgenic mice
with fluorescently labeled L cells paves the way for a new
wave of exploration into the mechanisms underlying GLP-1
and PYY release, with the potential to identify targets in L cells
that could be exploited therapeutically for the treatment of dia-
betes and obesity.
EXPERIMENTAL PROCEDURES
Constructs
BAC constructs containing the sequence of Venus driven by the rat and mouse
proglucagon promoters were made by the RedEt technique (Zhang et al.,
2000). For further details, see the Supplemental Data.
Intestinal Epithelial Cell Isolation
All animal procedures were approved by the local ethical committee and con-
formed to Home Office regulations. The 2- to 6-month-old Venus-expressing
transgenic mice were sacrificed by cervical dislocation and the gut collected
into ice-cold Leibovitz-15 (L-15) medium (PAA, UK). The small intestine (from
the stomach to ileocaecal junction) was divided either into thirds (top, mid,
and lower) or into halves, as indicated in the text, and colonic samples con-
sisted of gut tissue distal to the ileocolic junction. The intestine was opened,
rinsed in L-15, and chopped into 1–2 mm pieces. For flow cytometry, tissue
was digested twice for 30 min with 1 mg/ml Collagenase-XI in calcium-free
Hanks Balanced Salt Solution (HBSS) at 37C. Resulting cell suspensionsCellwere filtered through 70 mm nylon cell strainers (BD Falcon, UK), centrifuged
at 300 3 g for 5 min, and pellets resuspended in L-15 supplemented
with 10% fetal bovine serum (FBS). For culture, tissue was digested with
0.4 mg/ml Collagenase XI, centrifuged at 3003 g, and resuspended in Dulbec-
co’s modified Eagle’s medium (25 mM glucose) supplemented with 10% FBS,
2 mM L-glutamine, penicillin, and streptomycin. Aliquots were plated on matri-
gel-coated 24-well plates, 35 mm plastic dishes, or glass-bottom culture
dishes (Mattek Corporation, USA) for secretion, electrophysiology, and imag-
ing studies, respectively, and incubated for 1–12 days at 37C, 5% CO2.
Flow Cytometry
A MoFlo Beckman Coulter Cytomation sorter (488 nm excitation) was used to
separate populations of > 95% pure Venus-positive or -negative cells. Set-
tings: 90 mm nozzle, 38–40 psi, 58–60 kHz, plates charged with 3200 V. Single
cells were selected by their side and forward scatter and pulse width. Venus-
positive cells were selected by their relative fluorescence at 530 and 580 nm,
and Venus-negative cells by a gate that excluded Venus fluorescence. Cells
were sorted at numbers of up to 30,000 into either RNAlater (Ambion, UK) or
lysis buffer for protein extraction (see below).
RNA Extraction and Quantitative RT-PCR
Total RNA from FACS-sorted cells was isolated using a micro scale RNA iso-
lation kit (Ambion) and reverse transcribed according to standard protocols.
Quantitative RT-PCR was performed with 7900 HT Fast Real-Time PCR sys-
tem (Applied Biosystems). The PCR reaction mix consisted of first-strand
cDNA template, primer pairs (for details, see Supplemental Data), 6-carboxy-
fluorescein/quencher probes (Bioresearch Technologies, CA and Applied Bio-
systems), and PCR Master mix (Applied Biosystems). In all cases, expression
was compared with that of b-actin measured on the same sample in parallel on
the same plate, giving a CT difference (DCT) for b-actin minus the test gene.
CTs for b-actin ranged from 20–25 in the different samples, and reactions in
which the test gene was undetectable were assigned a CT value of 40.
ADCT value of12 to15 is, therefore, close to the detection limit of the assay.
Mean, standard error, and statistics were performed on the DCT data and only
converted to relative expression levels (2 ˆDCT) for presentation in the figures.
Hormone Secretion
Secretion studies were performed 24–36 hr after plating using tissue from ei-
ther transgenic or nontransgenic mice, as preliminary experiments showed
that the transgene had no effect on GLP-1 secretion (data not shown). Cultures
were incubated with test reagents in bath solution (see below) containing 0.1%
fatty acid-free BSA for 2–4 hr at 37C. Media was collected and centrifuged to
remove contaminating cells. Cells were then treated with lysis buffer contain-
ing: 50 mM Tris-HCl, 150 mM NaCl, 1% IGEPAL-CA 630, 0.5% deoxycholic
acid, and one tablet of complete EDTA-free protease inhibitor cocktail (Roche)
to extract intracellular peptides. GLP-1 was assayed in supernatants and cell
extracts using an active GLP-1 ELISA-kit (Millipore, USA); PYY was assayed
using a total peptide YY ELISA kit (Diagnostic Systems Laboratories, Inc.,
USA) and GIP by a rodent GIP total ELISA kit (Millipore, USA). Hormone secre-
tion was expressed as a fraction of the total of that hormone measured in each
well and normalized, as indicated, to the basal secretion measured in parallel
on the same day.
Calcium Imaging
Experiments were performed on 3- to 12-day-old cultures. Cells were loaded
in 7 mM fura2-AM (Invitrogen, UK) and 0.01% pluronic F127 and incubated in
standard bath solution containing 10 mM glucose and 300 mM eserine for
30 min at 37C. Experiments were performed using an inverted fluorescence
microscope (Eclipse TE2000, Nikon, UK) with a 403 oil-immersion objective.
Fura2 was excited at 340 and 380 nm and Venus at 475 nm using a 75 W xenon
arc lamp and a monochromator (Cairn Research, Faversham, UK) controlled
by MetaFluor software (Molecular Devices, UK). Emission was recorded with
a QuantEM CCD camera (Photometrics, Roper Scientific, UK). Fura2 fluores-
cence measurements were taken every 2 s, background corrected, and ex-
pressed as the 340/380 nm ratio. Solutions were perfused at 1 ml/min, and
test agents were added for 2–5 min. Average fluorescence ratios were deter-
mined over 20 s periods under control conditions (before addition of and afterMetabolism 8, 532–539, December 3, 2008 ª2008 Elsevier Inc. 537
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Glucose Sensing by L Cellswashout of the test agent) and at the time of the maximum response during ap-
plication of the agent.
Electrophysiology
Experiments were performed on 3- to 12-day-old colonic cultures at 22–25C
using techniques and pipette solutions described previously for the study of
GLUTag cells (Reimann and Gribble, 2002; Simpson et al., 2007). Slope con-
ductance was calculated for the linear part of the current-voltage relationship
between 70 to 50 mV.
Solutions
Standard bath solution contained (mM) 4.5 KCl, 138 NaCl, 4.2 NaHCO3,
1.2 NaH2PO4, 2.6 CaCl2, 1.2 MgCl2, and 10 HEPES (pH 7.4, NaOH). All chem-
icals were supplied by Sigma Aldrich (Poole, UK) unless otherwise stated.
Immunohistochemistry
See Supplemental Data.
Data Analysis
Comparisons involving multiple conditions were performed initially either by
ANOVA or regression analysis and, subsequently, by Student’s two-sample
or one-sample t tests (Microsoft Excel), as indicated, with a threshold for
significance of p = 0.05. Dose-response curves for glucose-triggered GLP-1
release were fit with a logistic equation and compared using a comparison
of fits analysis using Microcal Origin software.
SUPPLEMENTAL DATA
The Supplemental Data for this article include Supplemental Experimental
Procedures, three figures, and three tables and can be found with this article
at http://www.cell.com/cell-metabolism/S1550-4131(08)00354-9.
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